Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Prediction of 177Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on 68Ga-DOTATATE PET/CT.
Journal: Cancers
Published: December 11, 2023
Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
Journal: JAMA network open
Published: March 23, 2021
Abnormal Pretreatment Liver Function Tests Are Associated with Discontinuation of Peptide Receptor Radionuclide Therapy in a U.S.-Based Neuroendocrine Tumor Cohort.
Journal: The oncologist
Published: September 27, 2019
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
Journal: Clinical breast cancer
Published: February 24, 2019
Showing 1-4 of 4
Last Updated: 09/26/2026